Aagami, Inc.

Aagami is a CRO providing Clinical Trials (all Phases) Pre Clinical services to BioPharma industries worldwide. Aagami provides these High Quality Cost Effective Contract Research using ICH-GLP, GCP & GMP certified Labs & sites in India. Our services stretch your budgets to accomplish more for the same amount. We are committed to quality, integrity, speed and affordability of research.

Activity:

- Clinical Trials
- Contract Manufacturing
- Contract Research
- Market Research & Marketing
- Regulatory Affairs & Legal Services
- Sales & Distribution

Product / Technology type(s) covered:

- API / chemicals
- Bio
- Cosmoceuticals
- Curative
- Devices
- Drug delivery
- Generics
- NCE (new chemical entities)
- Pharmaceuticals / Therapeutics
- Nutritionals / Vitamins
- Proteins

Therapeutic targets:

- Aging
- AIDS
- Allergy
- Alzheimer's Disease
- Arthritis / Rheumato
- Asthma
- Cancer
- Cardiovascular
- Central nervous system
- Cough / Cold
- Dermatology
- Diabetes
- Epidemiology
- Gastrointestinal
- Genetics
- Geriatrics
- Hematology
- Infectious Diseases
- Men's Health
- Mental Health
- Neurology
- Obesity
- Oncology
- Ophthalmology
- Orthopedics
- Pain
- Pediatrics
- Radiology
- Reproductive Health
- Respiratory Medicine
- Stroke
- Surgery
- Urology
- Women's Health

Markets Covered

a. HeadQuarter: United States of America

b. Continent(s) active: North America , Europe , Asia , Australia/New-Zealand , Far East

c. Countries active: US, Canada, Japan, Korea, Taiwan, UK, Germany, France, Spain, Italy, Benelux, Scandinavia, Australia, New Zealand, Singapore

Corporate data:

Number of Employees: 5

Turnover:

Amount:	Year:	Currency:
1 Million	2006	US Dollar

Year founded: 2002

Partners / Alliances: Aagami has strategic partnership with

1. Shasun Chemicals and Drugs Ltd. and their group companies for Custom Synthesis in Specialty Chemicals

2. Shantha Biotechnic for Biologics and protein manufacturing

3. Apothecaries Ltd. and their group companies for Clinical Trials from Phase I through IV including Bio-equivalence studies